• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

再生医学中的间充质干细胞:关节软骨和椎间盘组织工程的机遇与挑战

Mesenchymal stem cells in regenerative medicine: opportunities and challenges for articular cartilage and intervertebral disc tissue engineering.

作者信息

Richardson Stephen M, Hoyland Judith A, Mobasheri Reza, Csaki Constanze, Shakibaei Mehdi, Mobasheri Ali

机构信息

Tissue Injury and Repair Group, Faculty of Medical and Human Sciences, University of Manchester, Manchester, UK.

出版信息

J Cell Physiol. 2010 Jan;222(1):23-32. doi: 10.1002/jcp.21915.

DOI:10.1002/jcp.21915
PMID:19725073
Abstract

Defects of load-bearing connective tissues such as articular cartilage and intervertebral disc (IVD) can result from trauma, degenerative, endocrine, or age-related disease. Current surgical and pharmacological options for the treatment of arthritic rheumatic conditions in the joints and spine are ineffective. Cell-based surgical therapies such as autologous chondrocyte transplantation (ACT) have been in clinical use for cartilage repair for over a decade but this approach has shown mixed results. This review focuses on the potential of mesenchymal stem cells (MSCs) as an alternative to cells derived from patient tissues in autologous transplantation and tissue engineering. Here we discuss the prospects of using MSCs in regenerative medicine and summarize the advantages and disadvantages of these cells in articular cartilage and IVD tissue engineering. We discuss the conceptual and practical difficulties associated with differentiating and pre-conditioning MSCs for subsequent survival in a physiologically harsh extracellular matrix, an environment that will be highly hypoxic, acidic, and nutrient deprived. Implanted MSCs will be exposed to traumatic physical loads and high levels of locally produced inflammatory mediators and catabolic cytokines. We also explore the potential of culture models of MSCs, fully differentiated cells and co-cultures as "proof of principle" ethically acceptable "3Rs" models for engineering articular cartilage and IVD in vitro for the purpose of replacing the use of animals in arthritis research.

摘要

承重结缔组织的缺陷,如关节软骨和椎间盘(IVD),可能由创伤、退行性病变、内分泌或与年龄相关的疾病引起。目前用于治疗关节和脊柱关节炎性风湿疾病的手术和药物治疗方法效果不佳。基于细胞的手术疗法,如自体软骨细胞移植(ACT),已在临床用于软骨修复十多年,但这种方法的效果参差不齐。本综述重点关注间充质干细胞(MSCs)在自体移植和组织工程中作为替代患者组织来源细胞的潜力。在此,我们讨论了在再生医学中使用MSCs的前景,并总结了这些细胞在关节软骨和IVD组织工程中的优缺点。我们讨论了在生理上恶劣的细胞外基质中分化和预处理MSCs以使其随后存活所涉及的概念和实际困难,这种环境将是高度缺氧、酸性和营养缺乏的。植入的MSCs将暴露于创伤性物理负荷以及高水平的局部产生的炎症介质和分解代谢细胞因子。我们还探讨了MSCs、完全分化细胞和共培养的培养模型作为“原理证明”的潜在可能性,这些模型是在体外工程化关节软骨和IVD的符合伦理的可接受的“3Rs”模型,目的是在关节炎研究中替代动物的使用。

相似文献

1
Mesenchymal stem cells in regenerative medicine: opportunities and challenges for articular cartilage and intervertebral disc tissue engineering.再生医学中的间充质干细胞:关节软骨和椎间盘组织工程的机遇与挑战
J Cell Physiol. 2010 Jan;222(1):23-32. doi: 10.1002/jcp.21915.
2
Mesenchymal stem cells for cartilage engineering.用于软骨工程的间充质干细胞。
Biomed Mater Eng. 2012;22(1-3):69-80. doi: 10.3233/BME-2012-0691.
3
Feasibility of a stem cell therapy for intervertebral disc degeneration.一种用于椎间盘退变的干细胞疗法的可行性。
Spine J. 2008 Nov-Dec;8(6):888-96. doi: 10.1016/j.spinee.2007.09.011. Epub 2007 Dec 21.
4
Mesenchymal stem cells in regenerative medicine: Focus on articular cartilage and intervertebral disc regeneration.再生医学中的间充质干细胞:聚焦于关节软骨和椎间盘再生。
Methods. 2016 Apr 15;99:69-80. doi: 10.1016/j.ymeth.2015.09.015. Epub 2015 Sep 15.
5
Mesenchymal stem cells as a potential pool for cartilage tissue engineering.间充质干细胞作为软骨组织工程的潜在细胞来源
Ann Anat. 2008 Nov 20;190(5):395-412. doi: 10.1016/j.aanat.2008.07.007. Epub 2008 Aug 28.
6
Repair of full-thickness articular cartilage defects by cultured mesenchymal stem cells transfected with the transforming growth factor beta1 gene.用转染了转化生长因子β1基因的培养间充质干细胞修复全层关节软骨缺损
Biomed Mater. 2006 Dec;1(4):206-15. doi: 10.1088/1748-6041/1/4/006. Epub 2006 Sep 22.
7
Mechanobiological conditioning of stem cells for cartilage tissue engineering.用于软骨组织工程的干细胞的力学生物学调控
Biomed Mater Eng. 2006;16(4 Suppl):S37-52.
8
Adult mesenchymal stem cells for tissue engineering versus regenerative medicine.用于组织工程与再生医学的成人间充质干细胞。
J Cell Physiol. 2007 Nov;213(2):341-7. doi: 10.1002/jcp.21200.
9
[Experimental research on repair of rabbit articular cartilage deffects with composite of autologous cell-carriers].自体细胞载体复合物修复兔关节软骨缺损的实验研究
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2008 Apr;22(4):487-91.
10
Enhanced treatment of articular cartilage defect of the knee by intra-articular injection of Bcl-xL-engineered mesenchymal stem cells in rabbit model.经 Bcl-xL 工程化间充质干细胞关节内注射治疗兔膝关节软骨缺损。
J Tissue Eng Regen Med. 2010 Feb;4(2):105-14. doi: 10.1002/term.212.

引用本文的文献

1
Bone Mesenchymal Stem Cells Inhibit Oxidative Stress-Induced Pyroptosis in Annulus Fibrosus Cells to Alleviate Intervertebral Disc Degeneration Based on Matric Hydrogels.基于基质水凝胶,骨髓间充质干细胞抑制氧化应激诱导的纤维环细胞焦亡以减轻椎间盘退变
Appl Biochem Biotechnol. 2024 Nov;196(11):8043-8057. doi: 10.1007/s12010-024-04953-z. Epub 2024 Apr 27.
2
Analysis of the mechanism of curcumin against osteoarthritis using metabolomics and transcriptomics.基于代谢组学和转录组学分析姜黄素抗骨关节炎的作用机制。
Naunyn Schmiedebergs Arch Pharmacol. 2024 May;397(5):3313-3329. doi: 10.1007/s00210-023-02785-y. Epub 2023 Nov 8.
3
Intervertebral disc degeneration-Current therapeutic options and challenges.
椎间盘退变——当前的治疗选择和挑战。
Front Public Health. 2023 Jul 6;11:1156749. doi: 10.3389/fpubh.2023.1156749. eCollection 2023.
4
Effects of glucose concentration and oxygen partial pressure on the respiratory metabolism of sheep temporomandibular joint disc cells.葡萄糖浓度和氧分压对绵羊颞下颌关节盘细胞呼吸代谢的影响。
Exp Ther Med. 2023 Jun 29;26(2):387. doi: 10.3892/etm.2023.12086. eCollection 2023 Aug.
5
Intra-Articular Lactate Dehydrogenase A Inhibitor Oxamate Reduces Experimental Osteoarthritis and Nociception in Rats via Possible Alteration of Glycolysis-Related Protein Expression in Cartilage Tissue.关节内乳酸脱氢酶 A 抑制剂草氨酸减少大鼠实验性骨关节炎和痛觉过敏,可能通过改变软骨组织中糖酵解相关蛋白表达。
Int J Mol Sci. 2023 Jun 28;24(13):10770. doi: 10.3390/ijms241310770.
6
Potential Role for Stem Cell Regenerative Therapy as a Treatment for Degenerative Disc Disease and Low Back Pain: A Systematic Review.干细胞再生治疗作为退行性椎间盘疾病和下腰痛治疗方法的潜在作用:系统评价。
Int J Mol Sci. 2023 May 17;24(10):8893. doi: 10.3390/ijms24108893.
7
The Effect of the Mechanical Properties of the 3D Printed Gelatin/Hyaluronic Acid Scaffolds on hMSCs Differentiation Towards Chondrogenesis.3D 打印明胶/透明质酸支架的机械性能对 hMSCs 向软骨分化的影响。
Tissue Eng Regen Med. 2023 Jul;20(4):593-605. doi: 10.1007/s13770-023-00545-w. Epub 2023 May 17.
8
Injectable Colloidal Hydrogels of -Vinylformamide Microgels Dispersed in Covalently Interlinked pH-Responsive Methacrylic Acid-Based Microgels.分散在共价交联的 pH 响应性甲基丙烯酸酯基微凝胶中的 - 乙烯基甲酰胺微凝胶的可注射胶体水凝胶。
Biomacromolecules. 2023 May 8;24(5):2173-2183. doi: 10.1021/acs.biomac.3c00058. Epub 2023 Apr 7.
9
Low Back Pain, Disability, and Quality of Life One Year following Intradiscal Injection of Autologous Bone Marrow Aspirate Concentrate.椎间盘内注射自体骨髓抽吸浓缩物一年后的腰痛、残疾情况及生活质量
Stem Cells Int. 2022 Dec 12;2022:9617511. doi: 10.1155/2022/9617511. eCollection 2022.
10
Adipose-Derived Stem Cells (ASCs) for Regeneration of Intervertebral Disc Degeneration: Review Article.用于椎间盘退变再生的脂肪来源干细胞(ASCs):综述文章。
Stem Cells Cloning. 2022 Nov 4;15:67-76. doi: 10.2147/SCCAA.S379714. eCollection 2022.